ArticleOncoimmunology

Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy.

B Montico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.